124 related articles for article (PubMed ID: 33682555)
21. Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK.
Kypridemos C; Collins B; McHale P; Bromley H; Parvulescu P; Capewell S; O'Flaherty M
PLoS Med; 2018 May; 15(5):e1002573. PubMed ID: 29813056
[TBL] [Abstract][Full Text] [Related]
22. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.
Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T
Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176
[TBL] [Abstract][Full Text] [Related]
23. Home environmental assessments and modification delivered by occupational therapists to reduce falls in people aged 65 years and over: the OTIS RCT.
Cockayne S; Pighills A; Adamson J; Fairhurst C; Crossland S; Drummond A; Hewitt CE; Rodgers S; Ronaldson SJ; McCaffery J; Whiteside K; Scantlebury A; Robinson-Smith L; Cochrane A; Lamb SE; Boyes S; Gilbody S; Relton C; Torgerson DJ
Health Technol Assess; 2021 Jul; 25(46):1-118. PubMed ID: 34254934
[TBL] [Abstract][Full Text] [Related]
24. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
25. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
[TBL] [Abstract][Full Text] [Related]
26. A multidomain decision support tool to prevent falls in older people: the FinCH cluster RCT.
Logan PA; Horne JC; Allen F; Armstrong SJ; Clark AB; Conroy S; Darby J; Fox C; Gladman JR; Godfrey M; Gordon AL; Irvine L; Leighton P; McCartney K; Mountain G; Robertson K; Robinson K; Sach TH; Stirling S; Wilson EC; Sims EJ
Health Technol Assess; 2022 Jan; 26(9):1-136. PubMed ID: 35125131
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of offering free leisure centre memberships to physically inactive members of the public receiving state benefits: a case study.
Verhoef TI; Trend V; Kelly B; Robinson N; Fox P; Morris S
BMC Public Health; 2016 Jul; 16():616. PubMed ID: 27449787
[TBL] [Abstract][Full Text] [Related]
28. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
29. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A
Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
[TBL] [Abstract][Full Text] [Related]
30. The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study.
Mytton OT; Jackson C; Steinacher A; Goodman A; Langenberg C; Griffin S; Wareham N; Woodcock J
PLoS Med; 2018 Mar; 15(3):e1002517. PubMed ID: 29509767
[TBL] [Abstract][Full Text] [Related]
31. Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis.
Whiting P; Al M; Burgers L; Westwood M; Ryder S; Hoogendoorn M; Armstrong N; Allen A; Severens H; Kleijnen J
Health Technol Assess; 2014 Mar; 18(18):1-106. PubMed ID: 24656117
[TBL] [Abstract][Full Text] [Related]
32. Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation.
Claxton L; Simmonds M; Beresford L; Cubbon R; Dayer M; Gottlieb SS; Hartshorne-Evans N; Kilroy B; Llewellyn A; Rothery C; Sharif S; Tierney JF; Witte KK; Wright K; Stewart LA
Health Technol Assess; 2022 Jan; 26(4):1-128. PubMed ID: 35076012
[TBL] [Abstract][Full Text] [Related]
33. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
[TBL] [Abstract][Full Text] [Related]
34. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
[TBL] [Abstract][Full Text] [Related]
35. Diabetes prevention at scale: Narrative review of findings and lessons from the DIPLOMA evaluation of the NHS Diabetes Prevention Programme in England.
Bower P; Soiland-Reyes C; Heller S; Wilson P; Cotterill S; French D; Sutton M
Diabet Med; 2023 Nov; 40(11):e15209. PubMed ID: 37634235
[TBL] [Abstract][Full Text] [Related]
36. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.
Pavey TG; Anokye N; Taylor AH; Trueman P; Moxham T; Fox KR; Hillsdon M; Green C; Campbell JL; Foster C; Mutrie N; Searle J; Taylor RS
Health Technol Assess; 2011 Dec; 15(44):i-xii, 1-254. PubMed ID: 22182828
[TBL] [Abstract][Full Text] [Related]
37. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
Frampton G; Harris P; Cooper K; Lotery A; Shepherd J
Health Technol Assess; 2014 Nov; 18(68):1-205, v-vi. PubMed ID: 25405576
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of the NHS breast screening programme: life table model.
Pharoah PD; Sewell B; Fitzsimmons D; Bennett HS; Pashayan N
BMJ; 2013 May; 346():f2618. PubMed ID: 23661112
[TBL] [Abstract][Full Text] [Related]
39. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
Elliott RA; Tanajewski L; Gkountouras G; Avery AJ; Barber N; Mehta R; Boyd MJ; Latif A; Chuter A; Waring J
Pharmacoeconomics; 2017 Dec; 35(12):1237-1255. PubMed ID: 28776320
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
